LABT
Lakewood-Amedex Biotherapeutics Inc.
Key Financials
Operating Income
$-4676410
N/A
Net Income
$-4695299
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/29/2026 | View on SEC |
| EFFECT | 9/24/2026 | View on SEC |
| S-1 | 9/18/2026 | View on SEC |
| DRS | 8/24/2026 | View on SEC |
| 424B3 | 8/17/2026 | View on SEC |
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| DEFA14A | 8/10/2026 | View on SEC |
| DEF 14A | 8/10/2026 | View on SEC |
| SCHEDULE 13G | 8/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LABT |
| Company Name | Lakewood-Amedex Biotherapeutics Inc. |
| CIK | 2079272 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 9412252515 |